Envoy Medical, Inc. is a medical device company focused on implantable hearing solutions, best known for the Esteem totally implantable active middle ear implant. The company went public through a merger with Anzu Special Acquisition Corp I, a blank-check company sponsored by Anzu Partners LLC that completed its IPO in 2021. The business combination closed in early 2023, after which the combined entity began trading on Nasdaq under the ticker ANZU. The May 2023 Form 10-Q reflects the company's first full quarterly reporting period as a publicly traded medical device issuer in the hearing health sector. For full SPAC deal data, filings history, and post-merger analytics on ANZU and thousands of other transactions, sign up for a SpacDesk account at spacdesk.com.